Biontech Se Adr stock is traded at $87.51, with a volume of 690,077. It is up +1.92% in the last 24 hours and down -8.59% over the past month. BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Previous Close:
$85.86
Open:
$85.60
24h Volume:
690,077
Relative Volume:
0.71
Market Cap:
$21.70B
Revenue:
$3.26B
Net Income/Loss:
-$1.45B
P/E Ratio:
-
EPS:
-$5.87
Net Cash Flow:
$1.18B
1W Performance:
-0.75%
1M Performance:
-8.59%
6M Performance:
-8.14%
1Y Performance:
-15.33%
1-Day Range:
$84.89$87.94
1-Week Range:
$84.89$91.46
52-Week Range:
$79.52$124.00
Biontech Se Adr Stock (BNTX) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS